
Two ways. You decide.
Integrate the technology into your own portfolio as a strategic partner, or invest in the category at seed stage. Both share the same upside.
aimee is a platform, not a single product. Platforms multiply:
Two ways to engage.
Strategic partner
Joint ventureCo-develop, co-scale. Integrate aimee into your product portfolio. Shared IP and go-to-market.
Financial investor
Investment roundFund, scale, return. Seed-stage entry into a platform technology. Multiple exit paths.
Performance and Health Applications
Sports & Lifestyle
Recovery biomarkers. Training optimization.
Pet care & livestock
Pets, livestock, equine. Performance and health.
Forensics
Rapid on-site testing. Portable and field-ready.
Fertility
Cycle tracking, IVF monitoring. From home.
Oncology
Treatment markers monitored over time. Confidence, not guesswork.
Chronic disease
Diabetes, kidney, heart. Recurring panels, no lab
Precision medicine
Right drug, right dose. Measured, not assumed.
…and many more
Similar sensor demands across adjacent fields.
Several verticals.
Multiple revenue streams.
One chip, multiple markets × one platform, multiple returns.
Choose the next step.
Get the executive summary (PDF)
Receive a one-page overview of the platform, potential commercial models and current status in exchange for your email.
Let’s explore a partnership.
Daniel Gillmann · CEO
daniel.gillmann@ricb-diagnostics.com